| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Hua Zhu | |
| Charles Warden | |||
| Qiyi Tang | |||
| P2860 | cites work | Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF. | Q40274387 |
| Conditional and reversible disruption of essential herpesvirus proteins. | Q52594500 | ||
| Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. | Q52857262 | ||
| Mutagenesis of viral BACs with linear PCR fragments (ET recombination). | Q54725610 | ||
| Rapid identification of essential and nonessential herpesvirus genes by direct transposon mutagenesis | Q57083076 | ||
| Epitopes on glycoprotein C of bovine herpesvirus-1 (BHV-1) that allow differentiation between BHV-1.1 and BHV-1.2 strains | Q77900046 | ||
| Herpesvirus of turkey reconstituted from bacterial artificial chromosome clones induces protection against Marek's disease | Q82781403 | ||
| Development of a gene capture method to rescue a large deletion mutant of human cytomegalovirus | Q83222849 | ||
| Cloning and stable maintenance of 300-kilobase-pair fragments of human DNA in Escherichia coli using an F-factor-based vector | Q24563904 | ||
| Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome | Q24645354 | ||
| Simple and highly efficient BAC recombineering using galK selection | Q24794075 | ||
| Retrofitting BACs with G418 resistance, luciferase, and oriP and EBNA-1 - new vectors for in vitro and in vivo delivery | Q24802976 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Functional profiling of a human cytomegalovirus genome | Q28185252 | ||
| A point mutation in a herpesvirus polymerase determines neuropathogenicity | Q28471604 | ||
| Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor | Q28474768 | ||
| Cloning human herpes virus 6A genome into bacterial artificial chromosomes and study of DNA replication intermediates | Q29030728 | ||
| An efficient recombination system for chromosome engineering in Escherichia coli | Q29615038 | ||
| A highly efficient Escherichia coli-based chromosome engineering system adapted for recombinogenic targeting and subcloning of BAC DNA | Q29615197 | ||
| Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes | Q30656734 | ||
| Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases | Q30826113 | ||
| Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes | Q30831669 | ||
| Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication | Q31094095 | ||
| The equine herpesvirus 1 UL34 gene product is involved in an early step in virus egress and can be efficiently replaced by a UL34-GFP fusion protein | Q31112624 | ||
| Molecular cloning of the guinea pig cytomegalovirus (GPCMV) genome as an infectious bacterial artificial chromosome (BAC) in Escherichia coli | Q31850123 | ||
| In vitro transposon mutagenesis of an equine herpesvirus 1 genome cloned as a bacterial artificial chromosome | Q33251132 | ||
| Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor | Q33311454 | ||
| A highly efficient protocol of generating and analyzing VZV ORF deletion mutants based on a newly developed luciferase VZV BAC system | Q40021337 | ||
| Genetic analysis of varicella-zoster virus ORF0 to ORF4 by use of a novel luciferase bacterial artificial chromosome system | Q40117236 | ||
| Mutagenesis of the herpesvirus saimiri terminal repeat region reveals important elements for virus production | Q40146691 | ||
| Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV). | Q40180359 | ||
| Felid herpesvirus 1 glycoprotein G is a structural protein that mediates the binding of chemokines on the viral envelope | Q40233947 | ||
| The UL4 gene of pseudorabies virus encodes a minor infected-cell protein that is dispensable for virus replication | Q40246196 | ||
| Genetic design of an optimized packaging cell line for gene vectors transducing human B cells. | Q40327889 | ||
| Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models | Q40327891 | ||
| Mutational analysis of the herpes simplex virus triplex protein VP19C. | Q40329080 | ||
| Epstein-Barr virus with the latent infection nuclear antigen 3B completely deleted is still competent for B-cell growth transformation in vitro | Q40446789 | ||
| Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system | Q40545950 | ||
| Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry | Q40551556 | ||
| Simultaneous deletion of pseudorabies virus tegument protein UL11 and glycoprotein M severely impairs secondary envelopment | Q40584553 | ||
| DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome | Q40588191 | ||
| Generation and precise modification of a herpesvirus saimiri bacterial artificial chromosome demonstrates that the terminal repeats are required for both virus production and episomal persistence | Q40611661 | ||
| Techniques in mammalian genome mapping | Q40614532 | ||
| Cloning of the genomes of human cytomegalovirus strains Toledo, TownevarRIT3, and Towne long as BACs and site-directed mutagenesis using a PCR-based technique | Q40659928 | ||
| Mutagenesis of a bovine herpesvirus type 1 genome cloned as an infectious bacterial artificial chromosome: analysis of glycoprotein E and G double deletion mutants | Q40673601 | ||
| Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors | Q40984259 | ||
| Epstein-Barr virus transforming protein LMP1 plays a critical role in virus production | Q41808994 | ||
| A Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50 deletion mutant is defective for reactivation of latent virus and DNA replication | Q42150768 | ||
| Differing roles of inner tegument proteins pUL36 and pUL37 during entry of herpes simplex virus type 1. | Q42151114 | ||
| Distinctive effects of the Epstein-Barr virus family of repeats on viral latent gene promoter activity and B-lymphocyte transformation | Q42546463 | ||
| Complete genomic sequence and an infectious BAC clone of feline herpesvirus-1 (FHV-1). | Q42653588 | ||
| HSV-1 amplicon-mediated transfer of 128-kb BMP-2 genomic locus stimulates osteoblast differentiation in vitro | Q42828329 | ||
| Evaluation of the vaccine potential of an equine herpesvirus type 1 vector expressing bovine viral diarrhea virus structural proteins | Q43036271 | ||
| Self-excision of the BAC sequences from the recombinant Marek's disease virus genome increases replication and pathogenicity | Q43052703 | ||
| Recombineering with tolC as a selectable/counter-selectable marker: remodeling the rRNA operons of Escherichia coli | Q43053415 | ||
| Cloning of the genomes of equine herpesvirus type 1 (EHV-1) strains KyA and racL11 as bacterial artificial chromosomes (BAC). | Q43537093 | ||
| Infectious clones of herpesviruses: a new approach for understanding viral gene function | Q44027332 | ||
| A Gateway recombination herpesvirus cloning system with negative selection that produces vectorless progeny | Q44928565 | ||
| Equine herpesvirus type 1 devoid of gM and gp2 is severely impaired in virus egress but not direct cell-to-cell spread | Q45030750 | ||
| Generation and characterization of an EICP0 null mutant of equine herpesvirus 1. | Q45294059 | ||
| Cloning and sequencing of a highly productive, endotheliotropic virus strain derived from human cytomegalovirus TB40/E. | Q45397798 | ||
| Protection of mice by equine herpesvirus type 1 based experimental vaccine against lethal Venezuelan equine encephalitis virus infection in the absence of neutralizing antibodies. | Q45397892 | ||
| Two Epstein-Barr virus (EBV) oncoproteins cooperate to repress expression of the proapoptotic tumour-suppressor Bim: clues to the pathogenesis of Burkitt's lymphoma. | Q45401541 | ||
| Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli | Q45589357 | ||
| Allele replacement: an application that permits rapid manipulation of herpes simplex virus type 1 genomes | Q45746975 | ||
| Two-step red-mediated recombination for versatile high-efficiency markerless DNA manipulation in Escherichia coli | Q45856655 | ||
| Protection against congenital cytomegalovirus (CMV) disease, conferred by a replication-disabled, bacterial artificial chromosome (BAC)-based DNA vaccine | Q46825500 | ||
| Genetic content of wild-type human cytomegalovirus | Q47709383 | ||
| The role of exonuclease and beta protein of phage lambda in genetic recombination. II. Substrate specificity and the mode of action of lambda exonuclease. | Q47756632 | ||
| An improved TnMax mini-transposon system suitable for sequencing, shuttle mutagenesis and gene fusions | Q48068157 | ||
| TnMax--a versatile mini-transposon for the analysis of cloned genes and shuttle mutagenesis | Q48105874 | ||
| The essential and non-essential genes of Bovine herpesvirus 1. | Q33377879 | ||
| Cloning of Bovine herpesvirus type 1 and type 5 as infectious bacterial artifical chromosomes | Q33510430 | ||
| Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome | Q33517637 | ||
| The DR1 and DR6 first exons of human herpesvirus 6A are not required for virus replication in culture and are deleted in virus stocks that replicate well in T-cell lines | Q33522355 | ||
| Autoexcision of bacterial artificial chromosome facilitated by terminal repeat-mediated homologous recombination: a novel approach for generating traceless genetic mutants of herpesviruses | Q33676526 | ||
| Systematic excision of vector sequences from the BAC-cloned herpesvirus genome during virus reconstitution. | Q33818345 | ||
| Reconstitution of Marek's disease virus serotype 1 (MDV-1) from DNA cloned as a bacterial artificial chromosome and characterization of a glycoprotein B-negative MDV-1 mutant | Q33826716 | ||
| Use of a murine cytomegalovirus K181-derived bacterial artificial chromosome as a vaccine vector for immunocontraception. | Q33833779 | ||
| DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters | Q33844093 | ||
| Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus | Q33866016 | ||
| Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus | Q33903818 | ||
| The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy | Q33918592 | ||
| Forward with BACs: new tools for herpesvirus genomics | Q33927285 | ||
| Identification of viral genes essential for replication of murine gamma-herpesvirus 68 using signature-tagged mutagenesis. | Q33928428 | ||
| Functional map of human cytomegalovirus AD169 defined by global mutational analysis | Q33972886 | ||
| Deletion of gpUL132, a structural component of human cytomegalovirus, results in impaired virus replication in fibroblasts | Q33987451 | ||
| Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway | Q34092628 | ||
| Recent advances in herpesvirus genetics using bacterial artificial chromosomes | Q34132209 | ||
| An exonuclease induced by bacteriophage lambda. II. Nature of the enzymatic reaction | Q34243330 | ||
| The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics | Q34345137 | ||
| Coding potential of laboratory and clinical strains of human cytomegalovirus | Q34388908 | ||
| Rapid genetic engineering of human cytomegalovirus by using a lambda phage linear recombination system: demonstration that pp28 (UL99) is essential for production of infectious virus. | Q34553401 | ||
| Comparison of vaccine strategies against congenital CMV infection in the guinea pig model | Q34722255 | ||
| Herpesvirus genetics has come of age. | Q34731380 | ||
| Construction of a self-excisable bacterial artificial chromosome containing the human cytomegalovirus genome and mutagenesis of the diploid TRL/IRL13 gene | Q34971048 | ||
| Cloning of the Full-Length Rhesus Cytomegalovirus Genome as an Infectious and Self-Excisable Bacterial Artificial Chromosome for Analysis of Viral Pathogenesis | Q34975353 | ||
| Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensable for infection of human skin and T cells in the SCID-hu mouse model | Q34977139 | ||
| Disruption of gammaherpesvirus 68 gene 50 demonstrates that Rta is essential for virus replication | Q34977295 | ||
| Two modes of herpesvirus trafficking in neurons: membrane acquisition directs motion. | Q35139587 | ||
| Functional characterization of Kaposi's sarcoma-associated herpesvirus ORF45 by bacterial artificial chromosome-based mutagenesis | Q35185925 | ||
| Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores | Q35539808 | ||
| Targeted disruption of Kaposi's sarcoma-associated herpesvirus ORF57 in the viral genome is detrimental for the expression of ORF59, K8alpha, and K8.1 and the production of infectious virus | Q35635202 | ||
| A self-recombining bacterial artificial chromosome and its application for analysis of herpesvirus pathogenesis | Q35700092 | ||
| Construction of an infectious rhesus rhadinovirus bacterial artificial chromosome for the analysis of Kaposi's sarcoma-associated herpesvirus-related disease development | Q35784917 | ||
| Replication-competent herpes simplex virus 1 isolates selected from cells transfected with a bacterial artificial chromosome DNA lacking only the UL49 gene vary with respect to the defect in the UL41 gene encoding host shutoff RNase. | Q36099301 | ||
| Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells | Q36173276 | ||
| Targeted deletion of regions rich in immune-evasive genes from the cytomegalovirus genome as a novel vaccine strategy. | Q36315171 | ||
| Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro | Q36465730 | ||
| A live guinea pig cytomegalovirus vaccine deleted of three putative immune evasion genes is highly attenuated but remains immunogenic in a vaccine/challenge model of congenital cytomegalovirus infection | Q36517130 | ||
| BAC-VAC, a novel generation of (DNA) vaccines: A bacterial artificial chromosome (BAC) containing a replication-competent, packaging-defective virus genome induces protective immunity against herpes simplex virus 1. | Q36551435 | ||
| Cloning of the koi herpesvirus genome as an infectious bacterial artificial chromosome demonstrates that disruption of the thymidine kinase locus induces partial attenuation in Cyprinus carpio koi. | Q36594136 | ||
| Epstein-Barr virus recombinants from overlapping cosmid fragments | Q36655212 | ||
| Varicella-zoster virus ORF 58 gene is dispensable for viral replication in cell culture | Q36699366 | ||
| A cosmid-based system for constructing mutants of herpes simplex virus type 1. | Q36753033 | ||
| The major portal of entry of koi herpesvirus in Cyprinus carpio is the skin. | Q37127960 | ||
| Differences in the regulatory and functional effects of the Us3 protein kinase activities of herpes simplex virus 1 and 2. | Q37410706 | ||
| A cyclooxygenase-2 homologue encoded by rhesus cytomegalovirus is a determinant for endothelial cell tropism. | Q37596973 | ||
| HSV as a vector in vaccine development and gene therapy | Q37666803 | ||
| Simple generation of site-directed point mutations in the Escherichia coli chromosome using Red(R)/ET(R) Recombination | Q38268186 | ||
| Detection of herpes simplex virus by measurement of luciferase activity in an infected-cell lysate | Q38569916 | ||
| Evaluation of the lytic origins of replication of Kaposi's sarcoma-associated virus/human herpesvirus 8 in the context of the viral genome | Q38760706 | ||
| Common and specific properties of herpesvirus UL34/UL31 protein family members revealed by protein complementation assay | Q39321803 | ||
| An enhanced packaging system for helper-dependent herpes simplex virus vectors | Q39580097 | ||
| Cloning and mutagenesis of the murine gammaherpesvirus 68 genome as an infectious bacterial artificial chromosome | Q39592358 | ||
| Construction and transposon mutagenesis in Escherichia coli of a full-length infectious clone of pseudorabies virus, an alphaherpesvirus. | Q39595184 | ||
| Cloning of the human cytomegalovirus (HCMV) genome as an infectious bacterial artificial chromosome in Escherichia coli: a new approach for construction of HCMV mutants. | Q39595874 | ||
| Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes | Q39602194 | ||
| Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis | Q39683622 | ||
| Construction and manipulation of an infectious clone of the bovine herpesvirus 1 genome maintained as a bacterial artificial chromosome | Q39683993 | ||
| Herpes simplex virus type 1 immediate-early protein ICP0 and is isolated RING finger domain act as ubiquitin E3 ligases in vitro | Q39686108 | ||
| Mutational analysis of the herpes simplex virus type 1 UL25 DNA packaging protein reveals regions that are important after the viral DNA has been packaged | Q39735560 | ||
| Role of murine cytomegalovirus US22 gene family members in replication in macrophages | Q39748997 | ||
| Analysis of herpes simplex virus type 1 DNA packaging signal mutations in the context of the viral genome | Q39782364 | ||
| Vaccination of mice with bacteria carrying a cloned herpesvirus genome reconstituted in vivo. | Q39789433 | ||
| Replication-competent bacterial artificial chromosomes of Marek's disease virus: novel tools for generation of molecularly defined herpesvirus vaccines. | Q39796541 | ||
| Clinical, virological, and immunological parameters associated with superinfection of latently with FeHV-1 infected cats | Q39862269 | ||
| Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids | Q39873911 | ||
| Re-engineering adenovirus vector systems to enable high-throughput analyses of gene function | Q39880319 | ||
| Characterization of pseudorabies virus (PrV) cleavage-encapsidation proteins and functional complementation of PrV pUL32 by the homologous protein of herpes simplex virus type 1. | Q39887429 | ||
| Effects of simultaneous deletion of pUL11 and glycoprotein M on virion maturation of herpes simplex virus type 1 | Q39917711 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | virus | Q808 |
| genetic vector | Q427389 | ||
| cell | Q7868 | ||
| bacterial structures | Q70189616 | ||
| P304 | page(s) | 124595 | |
| P577 | publication date | 2010-10-27 | |
| P1433 | published in | Journal of Biomedicine and Biotechnology | Q15752146 |
| P1476 | title | Herpesvirus BACs: past, present, and future | |
| P478 | volume | 2011 |
| Q40306707 | A distinct entorhinal cortex to hippocampal CA1 direct circuit for olfactory associative learning. |
| Q36607132 | A short cis-acting motif in the M112-113 promoter region is essential for IE3 to activate M112-113 gene expression and is important for murine cytomegalovirus replication |
| Q38791533 | An EBV recombinant deleted for residues 130-159 in EBNA3C can deregulate p53/Mdm2 and Cyclin D1/CDK6 which results in apoptosis and reduced cell proliferation |
| Q38226289 | An overview of live attenuated recombinant pseudorabies viruses for use as novel vaccines |
| Q40607067 | CTCF binding to the first intron of the major immediate early (MIE) gene of human cytomegalovirus (HCMV) negatively regulates MIE gene expression and HCMV replication |
| Q45363599 | Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome |
| Q42142126 | Complete Genome Sequence of a Cytomegalovirus Towne-BAC (Bacterial Artificial Chromosome) Isolate Maintained in Escherichia coli for 10 Years and Then Serially Passaged in Human Fibroblasts |
| Q39756019 | Complete Genome Sequence of a Human Cytomegalovirus Strain AD169 Bacterial Artificial Chromosome Clone |
| Q39323923 | Construction and manipulation of a new Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome clone |
| Q35944742 | Construction of a recombinant duck enteritis virus (DEV) expressing hemagglutinin of H5N1 avian influenza virus based on an infectious clone of DEV vaccine strain and evaluation of its efficacy in ducks and chickens |
| Q92280798 | Corrigendum to "Herpesvirus BACs: Past, Present, and Future" |
| Q45325143 | Effects of Shield1 on the viral replication of varicella‑zoster virus containing FKBP‑tagged ORF4 and 48. |
| Q30373912 | Efficient strategy for constructing duck enteritis virus-based live attenuated vaccine against homologous and heterologous H5N1 avian influenza virus and duck enteritis virus infection. |
| Q40259637 | Generating Recombinant Pseudorabies Virus for Use as a Vaccine Platform |
| Q39330196 | Generation and characterization of a Cowpox virus mutant lacking host range factor CP77. |
| Q40040343 | Generation of a novel human cytomegalovirus bacterial artificial chromosome tailored for transduction of exogenous sequences. |
| Q41934382 | Genome-wide engineering of an infectious clone of herpes simplex virus type 1 using synthetic genomics assembly methods |
| Q39130826 | Heterologous viral promoters incorporated into the human cytomegalovirus genome are silenced during experimental latency |
| Q24307542 | Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication |
| Q64260692 | Mutagenesis: A Method for Large-Scale Alteration of Viral Genomes |
| Q47242634 | Post-herpetic neuralgia - a review of current management and future directions |
| Q59354854 | Rapid and efficient in vitro excision of BAC sequences from herpesvirus genomes using Cre-mediated recombination |
| Q57017263 | Safety and immunogenicity of an attenuated Chinese pseudorabies variant by dual deletion of TK&gE genes |
| Q40659202 | Targeted Mutagenesis of Guinea Pig Cytomegalovirus Using CRISPR/Cas9-Mediated Gene Editing |
| Q37174468 | Two Polypyrimidine Tracts in Intron 4 of the Major Immediate Early Gene Are Critical for Gene Expression Switching from IE1 to IE2 and for Replication of Human Cytomegalovirus |
| Q90820627 | Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection |
| Q38264045 | Varicella zoster virus vaccines: potential complications and possible improvements |
Search more.